Barclay A. Phillips, Director at ACORDA THERAPEUTICS INC (ACOR), sold 235,000 shares at $30.60 ($7.1M) on 2008-06-13, disclosed to the SEC on 2008-06-16.
Open-market sale of $7.1M ACOR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.20 | 185,000 | $5.6M | 78.5% |
| 2 | $30.22 | 1,202 | $36K | 0.5% |
| 3 | $30.33 | 900 | $27K | 0.4% |
| 4 | $30.34 | 300 | $9K | 0.1% |
| 5 | $30.41 | 400 | $12K | 0.2% |
| 6 | $30.50 | 3,800 |
| $116K |
| 1.6% |
| 7 | $30.51 | 1,700 | $52K | 0.7% |
| 8 | $30.52 | 1,300 | $40K | 0.6% |
| 9 | $30.53 | 1,900 | $58K | 0.8% |
| 10 | $30.54 | 600 | $18K | 0.3% |
| 11 | $30.55 | 1,100 | $34K | 0.5% |
| 12 | $30.56 | 200 | $6K | 0.1% |
| 13 | $30.57 | 400 | $12K | 0.2% |
| 14 | $30.58 | 2,700 | $83K | 1.2% |
| 15 | $30.59 | 900 | $28K | 0.4% |
| 16 | $30.60 | 7,980 | $244K | 3.4% |
| 17 | $30.61 | 900 | $28K | 0.4% |
| 18 | $30.62 | 300 | $9K | 0.1% |
| 19 | $30.63 | 400 | $12K | 0.2% |
| 20 | $30.80 | 11,109 | $342K | 4.8% |
| 21 | $30.82 | 11,709 | $361K | 5.1% |
| 22 | $30.86 | 200 | $6K | 0.1% |
| Total | $30.30 avg | 235,000 | $7.1M | 100% |
| Filing → |
| NVAX | BUY | 2017-05-11 | $21K | — | Filing → |
| NVAX | BUY | 2017-02-02 | $2K | — | Filing → |
| NVAX | BUY | 2016-08-02 | $2K | — | Filing → |